article

Drug Target Review – Issue #3 2016

Posted: 20 September 2016 | Drug Target Review | No comments yet

In Issue #3 2016: Flow Cytometry, Enzymes, Imaging, GPCRs, Hit-To-Lead, CNS, Companion Diagnostics, and much more…

DTR Issue 3 iPad

In Issue #3 2016 of Drug Target Review:

  • FOREWORD: Paying to be obvious – ingenuity and patent law
    Jacob Gifford Head, Thomas More Chambers
  • FLOW CYTOMETRY: Breaking bottlenecks in drug discovery and development
    Pushpanathan Muthuirulan, National Institutes of Health and Pooja Sharma, University of Maryland
  • ENZYMES: Switching on genes regulating oxysterol synthesis – a therapeutic option?
    Steve Meaney, Dublin Institute of Technology
  • IMAGING IN-DEPTH FOCUS
    With articles from Norman Peterson, MedImmune/AstraZeneca, and Janet Brownlees, Emilie Bureau, Jenny Cook and Debra Taylor, MRC Technology
  • GPCRs: High-throughput calcium flux assays – luminescent versus fluorescent readout
    Nicolas Houvenaghel, Jans Mia, Van der Schueren Jan and Christophe Thierry, Galapagos NV
  • HIT-TO-LEAD IN-DEPTH FOCUS
    With contributions from Douglas B. Kitchen and Mark Wolf, Albany Molecular Research, and Martina Fenske and Sheraz Gul, Fraunhofer IME
  • CNS: Fibromyalgia pathogenesis provides drug target clues
    Kim Lawson, Sheffield Hallam University
  • COMPANION DIAGNOSTICS
    Interview with Pierre Belichard, CEO of Enterome Biosciences

Issue #3 2016 is restricted - login or subscribe free to access

Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend